OUR CLINICAL TRIALS

  • Status

  • Scenario

  • Patients population

  • Phase

  • Solti Program

  • Sites

  • Search

  • Reset


SOFT
A phase III trial evaluating the role of ovarian function suppression and exemestane as adjuvant Leer mas
SOFT-EST
Estrogen suppression substudy. Investigating estrogen suppression for patients participating in the SOFT trial – Arms Leer mas
SOLE
A phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 Leer mas
SOLO- SOLTI 1113
Sentinel lymph node total tumoral load as a predictor of non-sentinel node involvement in early Leer mas
SOLTI 0301 / CAPE-GEM
A phase II study of capecitabine and gemcitabine for the treatment of advanced breast cancer Leer mas
SOLTI-1910 RADIOLA
Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1, BRCA2, Leer mas
SOLTI-2201 ACROSS-TROP2
Prospective biomarker analysis in HR+/HER2- advanced or metastatic breast cancer patients treated with sacituzumab govitecan Leer mas
SU2C (BKM120)
A phase II trial of BKM120 (a PI3K inhibitor) in patients with triple negative metastatic Leer mas
TATEN
Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer, Leer mas